Three-drug combo improves lung function in most common genetic form of cystic fibrosis

Posted · Add Comment
scidaily-logo-rss

A phase three clinical trial determined that a 3-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.

This full article appears on <a href="https://www.sciencedaily.com/releases/2019/10/191031174701.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *